ADARx Pharmaceuticals, Inc. (ADRX) — Stock Valuation & Research

ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.

ADRX key statistics

Price$15.79
Market cap$1.75B
SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
52-week range15-23.21
Beta0

Explore ADRX's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.